Allstate Corp 8-K Report: Key Insights on Stock & Financing for Investors

Here are the key insights and information extracted from the provided section of the financial report:
- Entity Identification:
- Name: Allstate Corp
- CIK: 0000899051
- Location: 3100 Sanders Road, Northbrook, IL 60062
- Phone: 847-402-2800
- Filing Type:
- The report appears to be an 8-K filing, indicating a current report filed by a company to disclose major events that shareholders should know about.
- Reporting Period:
- Date of Report: February 20, 2025
- Stock Information:
- Common Stock:
- Par Value: $0.01 per share
- Trading Symbols:
- NYSE: ALL
- CHX: ALL
- Preferred Stocks:
- Series H:
- Type: Noncumulative Preferred Stock
- Dividend Rate: 5.100%
- Trading Symbol: ALL.PR.B
- Series I:
- Type: Noncumulative Preferred Stock
- Dividend Rate: 4.750%
- Trading Symbol: ALL.PR.I
- Series J:
- Type: Noncumulative Preferred Stock
- Dividend Rate: 7.375%
- Trading Symbol: ALL.PR.J
- Debt Instruments:
- 5.100% Fixed-to-Floating Rate Subordinated Debentures:
- Maturity Date: Due in 2053
- Trading Symbol: ALL.PR.B
- These debentures represent a significant form of financing for the company.
- Exchange Listings:
- The common stock and preferred stock are listed on major exchanges, specifically:
- NYSE (New York Stock Exchange)
- CHX (Chicago Stock Exchange)
- Financial Reporting Compliance:
- The report adheres to the XBRL (eXtensible Business Reporting Language) format, which is used for electronic filing with the SEC.
- Miscellaneous:
- The document includes various identifiers and dimensions related to the stock classes, indicating the structured data approach utilized in the filing. This enhances the clarity and accessibility of the financial information.
Overall, this section of the financial report provides valuable insights into Allstate Corp's stock offerings, preferred shares, and financing arrangements through subordinated debentures, pertinent for investors and financial analysts monitoring the company’s capital structure and financial health.